SlideShare a Scribd company logo
1 of 138
Dr. Md. Khairul Hassan Jessy
Associate Professor
Respiratory Medicine
NIDCH,Mohakhali,Dhaka
Self Management of Asthma
Introduction
To define the self management plan
To highlight the importance
To discuss the detailed procedure
Conclusion
In the last few years there have been
remarkable progress and
outstanding improvement
in the management of Asthma
But sadly, many patients of
developing countries are getting
unplanned
&
unscientific management
With
education, caution &
medication most cases of
asthma can be effectively managed
History
 Asthma was first recognized in
ancient Egypt
&
treatment was
inhalation of frankincense
Source : Wikipedia
History…..
 It was first
recognized as a
specific respiratory
problem &
named by
Hippocrates
History…..
History…
 The most recent advancement
is
Combination of ICS & LABA with
Adjustable Maintenance Dose (AMD)
or
Single Maintenance And Reliever Therapy
(SMART)
Asthma is a
chronic inflammatory disease affecting
the airways with typical symptoms of
cough, wheezing, breathlessness
& chest tightness
Unified definition
 Asthma is a chronic inflammatory disorder
 causing hyper-responsiveness of the airways to certain
stimuli
 resulting in recurrent variable airflow limitation
 at least partially reversible with treatment or spontaneously
 manifested as shortness of breath, wheeze, cough and
chest tightness
It is not a curable disease
But to a large extent
It is
controllable like Diabetes & Hypertension
It is not a curable disease
But to a large extent
It is
controllable like Diabetes & Hypertension
Use of
anti- inflammatory preventive drugs
for 2-5 years may lead to
Complete Remission in
60 – 80 % of Childhood asthma
20 – 30 % of Adult asthma
But many serious episodes can
be avoided by
proper education and
care at home
Pharmacological management
& Medicines of Asthma
Pharmacological management of Asthma…
The mainstay of asthma therapy is the
use of inhaled drugs
the advantages of this method are that drugs are
delivered direct to the airways and
avoid passage to the liver
Pharmacological management of Asthma…
thus lower doses are necessary and systemic
unwanted effect are minimized
The drugs used in asthma should be given in a
stepwise fashion according to the severity and
frequency of the attacks
Medicines of Asthma:
Medicine used to treat asthma are basically three
types
A) Relievers
B) Preventers
C) Protectors
A) Relievers
These medicines relax smooth muscles that
have tightened around the airways.
They relieve asthma symptoms.
A) Relievers (Bronchodilators)…
1. Short acting β2-
agonists (SABA)
Salbutamol
Terbutaline
2. Short acting
Xanthenes' derivatives
Theophylline
Aminophylline
3. Anticholinergics Ipratropium bromide
Oxitropium bromide
Tiotropium
B) Protectors
These medicines are long acting bronchodilator
medicines
 which prevent the recurrence of attacks
particularly nocturnal symptoms.
B) Protectors (Symptom controllers)
1) Long acting β2 agonist
(LABA)
Salmeterol
Formoterol
2) Long acting Xanthene
derivatives
Theophylline
Aminophylline
3) Sustained released
Salbutamol
C) Preventers
medicines reduce or reverse the swelling in the
airways
These medicines also prevent the initiation of
inflammation after exposure to trigger factors
Thereby they prevent asthma episodes
C) Preventers (Anti-inflammatory medicines)
I)Corticosteroids •Inhaled
•Oral
II) Cromones •Nedocromil sodium
•Sodium Cromoglycate
III) Xanthene derivatives •Aminophylline and
•Theophylline
IV) Antileukotrienes •CysLT-1 receptor inhibitor:
•Montelukast and
•Zafirlukast
•Enzyme inhibitor: Zileuton
Newer and Disease modifying Drugs
Newer Drugs
Omalizumab (Xoliar)
Magnesium Sulfate
Frusemide
Ciclesonide
Newer and Disease modifying Drugs…
Disease modifying agents
Methotraxte,
Cyclosporin-A &
Gold-salts
OMALIZUMAB (XOLIAR)
Considerations for IgE blocker Therapy
Monoclonal anti-IgE ab preparation
Inhibit binding of IgE to mast cell – does not
provoke mast cell degranulation
OMALIZUMAB (XOLIAR)
Considerations for IgE blocker Therapy…
 Patient at least 12 years of age
 Evidence of reversible disease (such as 12% or
greater improvement in FEV1 with at least a 200-
ml increase
 or 20% or greater improvement in PEF)
 IgE level ≥ 30 IU/ml
OMALIZUMAB (XOLIAR)
Considerations for IgE blocker Therapy…
 Systemic corticosteroids or high-dose inhaled
corticosteroids required to maintain adequate control
 As directly observable therapy in patients who are not
adherent to prescribed therapy
OMALIZUMAB (XOLIAR)
Considerations for IgE blocker Therapy…
An overview of asthma triggers
Asthma Triggers…
 A trigger is anything that irritates the airways
and causes the symptoms of asthma
 Normal healthy person is not bothered by those
triggers
Asthma Triggers…
Everyone's asthma is different and you may have
several triggers
An important aspect of controlling your asthma is
avoiding your triggers
It may be impossible to avoid all of your triggers
Asthma Triggers…
 but once you've identified them
 there are things you can do to help you to reduce
unnecessary symptoms and
better control of your asthma
Unhealthy indoor environment for
asthma patient
Asthma Triggers…
Why To identify asthma triggers?
To prevent some asthma attacks
To reduce the frequency and severity of some
attacks
The patient is trying to control
his asthma without removing
trigger factor
Asthma Triggers…
Detection of trigger by monitoring the lung
function
To control asthma, PEP (Positive Expiratory
Pressure) is so important that if they are
educated properly, then-
73% of hospital admission from acute attack
of asthma can be reduced and
80% of death from asthma can be prevented
Effortless easy breathing
- is our goal
24 hours a day
30 days a month
12 months a year
-with an intention for full remission
Non- Pharmacological
- Education
- Caution
Pharmacological
- Medications used in management
We should educate our people
in their own language
Based on
- our scientific knowledge
- less scientific terminology
- less comprehensive patho-physiology
GINA aims
GINA guidelines
published
Implementation
GINA guidelines
How are we
doing?
Patients? Physicians?
Healthcare
system?
Asthma control
Who is responsible for asthma
control?
Researchers?
41.1
14.5
35.4
Asia PacificEuropeUSA
% of patients
100
0
80
60
20
40
Rabe et al. Eur Respir J 2000;
www.asthmainamerica.com;
Lai et al. J Allergy Clin Immunol 2003
Patients with persistent asthma receiving controller therapy
Asthma control in practice was poor
Doctors didn't follow
 guidelines,
 underestimate severity and
 may confuse severity with control
Patients underestimate
the severity of their own disease
Guidelines were complex and can be difficult
to follow
Only 5% of patients achieved GINA-defined
control
Control of asthma means, patient-
is almost asymtomatic
can perform normal daily activities
requires reliever bronchodilator(sulbutamol
inhalation)<1 time a day
is free of nocturnal symptoms; if occurs , less
than two times per month
has PEFR reading >80% of personal best result
has <10% diurnal variability in Peak Flow Chart,
if available
 has no history of emergency visit to doctors
or hospitals
 has no or minimal side effects of medication
If we educate our patient properly
Then patient will cautiously avoid allergens
to control bronchial asthma
They will use their medications with an
intension to get remission
Includes –
Home Management
- of stable asthma
Emergency Management
-Loss of control of asthma
-Difficult to treat asthma
Asthma is a chronic disease and it should be
managed at home, except severe acute asthma
 If home management plan is applied intelligently
and skillfully most asthmatics can lead a
symptom-free near-normal life
 They may avoid hospitalization thereby
decreasing the financial expenditure significantly
There are two types of plans
 without self-management plan
 with guided self-management plan
 The patient is educated
 Appropriate precautionary measures
are advised
 “Step care management’’ is employed
 The prescription is quite inflexible
whatever be the condition
 patient will not increase the drugs
except β 2 agonist ( salbutamol )
inhaler
 Salbutamol inhaler may be taken as per
need upto 4-6 times / day
Development of a guide on the basis of
best Peak Flow is known as guided self
management plan.
Patient will measure his lung function with
the help of a peak flow meter and on the
basis of best peak flow results, patients will
modify their treatment.
Peak Flow Meter
 lead a symptom free near normal life
 avoid many serious episodes of acute
asthma &
 Chances of mortality and morbidity is
reduced considerably
 Time consuming
 More laborious
 Needs patient compliance
Flow meters are devices to measure
the strength of airways (force of
inspiration and expiration)
Types of flow meters are
 Peak expiratory flow meter ( peak flow
meter)
 Incentive Spirometer
 Peak inspiratory flow meter ( PIF )
 The measurement of peak expiratory
flow was pioneered by Martin Wright
 who produced the first meter to
measure lung function
 The original design of instrument was
introduced in the late 1950s
 and the subsequent development of a more
portable, lower cost version is the "Mini-
Wright" peak flow meter
Who Should Use a Peak Flow Meter?
People with moderate-to-severe asthma should have a
peak flow meter at home.
Even Peak flow meters are very helpful if a child have
moderate to severe asthma and require daily asthma
medications.
Most children ages 6 and up may be able to use a
peak flow meter.
PEF(Peak expiratory flow):
It is the highest flow one can achieve
during forceful expiration
The peak flow meter
measures how fast air comes out of
the lungs when a person exhale
forcefully after inhaling fully
Inexpensive, portable & handy device.
Only measures the amount of airflow out of the large
airways of the lungs.
Small airways (which also occur with asthma) will not
be detected by a peak flow meter.
Depends on a patient's sex, age and height.
 Move the marker to the bottom of the
numbered scale.
 Stand up if you're able.
 Take a deep breath, filling your lungs
completely.
 Place your lips tightly around the mouthpiece.
 Blow as hard and as fast as you can with a single
breath.
 Note the final position of the marker. This is
your peak flow rate.
 Follow the steps above then blow into the peak
flow meter two more times.
 Best of 3 blows is recorded.
To recognize early changes that may be signs of
worsening asthma and thus preventing asthma attack.
During an asthma attack, the muscles in the airways
tighten and cause the airways to narrow.
The peak flow meter alerts you to the tightening of
the airways often hours or even days before the
development of asthma symptoms.
By following the steps in asthma action plan,
patient may be able to
stop the narrowing of the airways
quickly and
avoid a severe asthma emergency
Mainly Used to find out
 early asthma attack (long before the
onset of symptoms) &
 by doubling the medicine a
serious episode can be avoided
 Used as a short term monitoring tool at
Doctor’s chamber & emergency room
during exacerbations
Long term monitoring of asthma
at patient’s home
by maintaining peak flow chart
essential for constructing self
management plan
Can also be used to see
whether the management plan is
working or not
 to decide when to add or stop
medicine
 to decide when the patient seeks
emergency care
 to identify triggers
By using own PEF with his/her asthma action
plan, he/she will know when to take his/her
rescue asthma inhaler or other asthma
medicine.
Diurnal variability =
(highest PEF – lowest PEF)X100
highest PEF
How to take care of Peak Flow
Meter?
Most peak flow meters require
weekly cleaning with warm water
and a mild detergent.
PEF varies throughout the day.
In a person who does not have asthma, it may
vary between 10% and 15%.
 In a person who has poorly controlled asthma,
it may vary more than 20%.
Peak Flow Chart
Peak Flow Chart
The highest peak flow measurement of a patient
achieved over a two week period when patient’s
asthma is totally/ well controlled
“Self management plan” needs to be constructed
depending on his own personal best peak flow value
A person's personal best is his or her highest peak flow.
Determine by taking readings over 2 weeks
when the asthma is under control.
Should be recorded at least twice daily.
Best is usually reached in the evening.
Never measured during an asthma attack.
Patient will-
Record his personal best peak flow result in the
prescribed peak flow diary or chart
3 zones will be demarcated in the diary
Take peak flow reading every morning on
waking up and night at bedtime
Peak flow readings should be taken at the same
time each day
They will also write down if they were exposed
to any trigger factor’s initiating an attack.
Patient will-
 Peak expiratory flow is lowest in the early
morning and highest in the afternoon.
 If patient wants to take the test only one time
during the day, they should take it first in the
morning, before using a bronchodilator
medicine.
 note how many times they took extra
reliever asthma medicine to stop their
symptoms every day
( 3 basic steps )( 3 basic steps )
Step 1Step 1
Patient will measure the lung function
with peak flow meter & maintain a
peak flow chart
( 3 basic steps )
Step 2
With this chart - patient’s personal
best peak flow result is
determined
On that basis readings are recorded in a
chart with 3 color zones :
Green,Yellow, Red
Peak Flow Chart
( 3 basic steps )
Step 3
Physician will develop one
prescription for each zone
Patient is educated to modify drugs
up to a certain limit
Peak Flow Zone System
3 traffic light colors are used to measure the
control of asthma
Green
Yellow
Red
Green zone indicates
well controlled asthma
Green zone ( safety zone )
peak flow 100 - 80 % of personal best
no/minimal symptoms
maintenance therapy continues
inhaled β 2 agonists may be used in some specific
situations
( before exercise / mild symptoms)
Yellow zone ( zone of alert )
- PEF is < 80 –> 60 % of personal best
o Asthma symptoms –
cough ( nocturnal )
breathlessness
wheezing may be present
Yellow zone ( zone of alert )…
suggestive of –
 Acute exacerbation or gradual deterioration of
severity of asthma
 Consultation with physician is needed .
 Patient will double his preventer drug and take one or
two oral protector drugs.
 Red zone ( zone of emergency )
This signals a medical alert
o PEF is < 60 % of personal best
o Asthma symptoms are present at rest and
interferes activity
o β 2 agonist should be taken immediately
o patient will start rescue oral steroid &
o should contact the physician ( may need
hospitalization )
Red Zone means
Along with prescription of yellow Zone
 patient will start rescue oral steroid and
 should contact a physician immediately
Scenario 1:
Mr. X , 45 years - known case of bronchial
Asthma & Allergic Rhinitis
 Personal best peak flow result
=500L/min
 Present PEFR = 420 l/min
Questions:
1.PEF Zone?
2.What treatment to be given?
Ans. 1. Green Zone
2.Rx
Inhaler Fluticasone/Salmaterol (125/25)
2 puffs 12 hourly (contd) (gargle after use)
Inhaler Salbutamol
2 puffs SOS
Tab. Montelukast 10 mg
0+0+1(contd)
Tab. Fexofenadine 120/Rupatidine 10
0+0+1 SOS
Fluticasone nasal spray
2 puffs once daily in the morning (sos)
Scenario 2:
Mr. X , 45 years - known case of bronchial
Asthma & Allergic Rhinitis
Personal best peak flow result=500L/min
Present PEFR = 350 l/min
Questions:
1.PEF Zone?
2.What treatment to be given?
Ans. 1.Yellow Zone
2.Rx:
Inhaler Fluticasone/Salmaterol(250/25)
2 puffs 12 hourly (contd)(gargle after use)
Inhaler Salbutamol
2 puffs sos
Tab. Montelukast 10 mg
0+0+1(contd)
Tab. Fexofenadine 120/Rupatidine 10
0+0+1 sos
Theophylline S.R.(200 mg)
0+0+1 (contd)
Fluticasone nasal spray
2 puffs once daily in the morning (contd)
Scenario 3:
Mr. X , 45 years - known case of bronchial
Asthma & Allergic Rhinitis
 Personal best peak flow result = 500 L/min
 Present PEFR = 150 l/min
Questions:
1.PEF Zone?
2.What treatment to be given?
Ans. 1.Red Zone
2.Rx
Tab. Prednisolone (20 mg)
2+0+0 (after meal) 7 days
Tab. Esomoprazole (20 mg)
1+0+1
+treatment of yellow zone
(to contact physician immediately)
Asthma is not a curable disease
But total/well control is possible in almost all
cases by
oproper Education
otaking Caution ( regarding
environmental control )&
oNeed for Medication.
Asthma is a chronic disease and it
should be managed at home except
severe acute asthma
THANKTHANK
YOU !YOU !

More Related Content

What's hot

Gina guidelines 2019
Gina guidelines 2019Gina guidelines 2019
Gina guidelines 2019Prateek Singh
 
Bronchial asthma in children
Bronchial asthma in childrenBronchial asthma in children
Bronchial asthma in childrenAsnaShareen
 
Management Of Acute Asthma
Management Of Acute AsthmaManagement Of Acute Asthma
Management Of Acute AsthmaDang Thanh Tuan
 
Wheezy chest in pediatrics
Wheezy chest in pediatrics Wheezy chest in pediatrics
Wheezy chest in pediatrics danielrawand
 
COPD(chronic obstructive pulmonary disease) ppt slideshare
COPD(chronic obstructive pulmonary disease) ppt slideshareCOPD(chronic obstructive pulmonary disease) ppt slideshare
COPD(chronic obstructive pulmonary disease) ppt slidesharesonam
 
Bronchial Asthma - Epidemiology, Pathogenesis and Management
Bronchial Asthma - Epidemiology, Pathogenesis and ManagementBronchial Asthma - Epidemiology, Pathogenesis and Management
Bronchial Asthma - Epidemiology, Pathogenesis and ManagementShashikiran Umakanth
 
TB in special situation 2022.pptx
TB in special situation 2022.pptxTB in special situation 2022.pptx
TB in special situation 2022.pptxSamiaa Sadek
 
Anatomy, Physiology And Pathology Of The Lung
Anatomy, Physiology And Pathology Of The LungAnatomy, Physiology And Pathology Of The Lung
Anatomy, Physiology And Pathology Of The LungDang Thanh Tuan
 
GINA 2019 presentation
GINA 2019 presentationGINA 2019 presentation
GINA 2019 presentationDewan Shafiq
 
Bronchial Asthma- Recent advances in management by Dr. Jebin Abraham
Bronchial Asthma- Recent advances in management by Dr. Jebin AbrahamBronchial Asthma- Recent advances in management by Dr. Jebin Abraham
Bronchial Asthma- Recent advances in management by Dr. Jebin AbrahamJebin Abraham
 
Peadiatric pneumonia by Teo Yan
Peadiatric pneumonia by  Teo YanPeadiatric pneumonia by  Teo Yan
Peadiatric pneumonia by Teo YanDr. Rubz
 
Bronchial asthma therapeutics and status asthmaticus
Bronchial asthma therapeutics and status asthmaticusBronchial asthma therapeutics and status asthmaticus
Bronchial asthma therapeutics and status asthmaticusDr Chinmaya Debasis Panda
 
Bronchial Asthma in Children
Bronchial Asthma in ChildrenBronchial Asthma in Children
Bronchial Asthma in ChildrenJackie San
 
Guidelines for the Use of Antibiotics in Respiratory Tract Infections
Guidelines for the Use of Antibiotics in Respiratory Tract InfectionsGuidelines for the Use of Antibiotics in Respiratory Tract Infections
Guidelines for the Use of Antibiotics in Respiratory Tract InfectionsAzad Haleem
 
Bronchial Asthma
Bronchial AsthmaBronchial Asthma
Bronchial AsthmaEneutron
 

What's hot (20)

Gina guidelines 2019
Gina guidelines 2019Gina guidelines 2019
Gina guidelines 2019
 
Bronchial asthma in children
Bronchial asthma in childrenBronchial asthma in children
Bronchial asthma in children
 
Management Of Acute Asthma
Management Of Acute AsthmaManagement Of Acute Asthma
Management Of Acute Asthma
 
Bronchitis lecture in children
Bronchitis lecture in childrenBronchitis lecture in children
Bronchitis lecture in children
 
Wheezy chest in pediatrics
Wheezy chest in pediatrics Wheezy chest in pediatrics
Wheezy chest in pediatrics
 
COPD(chronic obstructive pulmonary disease) ppt slideshare
COPD(chronic obstructive pulmonary disease) ppt slideshareCOPD(chronic obstructive pulmonary disease) ppt slideshare
COPD(chronic obstructive pulmonary disease) ppt slideshare
 
Bronchial Asthma - Epidemiology, Pathogenesis and Management
Bronchial Asthma - Epidemiology, Pathogenesis and ManagementBronchial Asthma - Epidemiology, Pathogenesis and Management
Bronchial Asthma - Epidemiology, Pathogenesis and Management
 
Status Asthamaticus
Status AsthamaticusStatus Asthamaticus
Status Asthamaticus
 
Asthma ppt
Asthma pptAsthma ppt
Asthma ppt
 
TB in special situation 2022.pptx
TB in special situation 2022.pptxTB in special situation 2022.pptx
TB in special situation 2022.pptx
 
Anatomy, Physiology And Pathology Of The Lung
Anatomy, Physiology And Pathology Of The LungAnatomy, Physiology And Pathology Of The Lung
Anatomy, Physiology And Pathology Of The Lung
 
GINA 2019 presentation
GINA 2019 presentationGINA 2019 presentation
GINA 2019 presentation
 
Bronchial Asthma- Recent advances in management by Dr. Jebin Abraham
Bronchial Asthma- Recent advances in management by Dr. Jebin AbrahamBronchial Asthma- Recent advances in management by Dr. Jebin Abraham
Bronchial Asthma- Recent advances in management by Dr. Jebin Abraham
 
Bronchial asthma
Bronchial asthmaBronchial asthma
Bronchial asthma
 
Peadiatric pneumonia by Teo Yan
Peadiatric pneumonia by  Teo YanPeadiatric pneumonia by  Teo Yan
Peadiatric pneumonia by Teo Yan
 
Bronchial asthma therapeutics and status asthmaticus
Bronchial asthma therapeutics and status asthmaticusBronchial asthma therapeutics and status asthmaticus
Bronchial asthma therapeutics and status asthmaticus
 
Bronchiolitis
BronchiolitisBronchiolitis
Bronchiolitis
 
Bronchial Asthma in Children
Bronchial Asthma in ChildrenBronchial Asthma in Children
Bronchial Asthma in Children
 
Guidelines for the Use of Antibiotics in Respiratory Tract Infections
Guidelines for the Use of Antibiotics in Respiratory Tract InfectionsGuidelines for the Use of Antibiotics in Respiratory Tract Infections
Guidelines for the Use of Antibiotics in Respiratory Tract Infections
 
Bronchial Asthma
Bronchial AsthmaBronchial Asthma
Bronchial Asthma
 

Similar to Self Management of Asthma

gina guidelines 2015 asthama
gina guidelines 2015 asthamagina guidelines 2015 asthama
gina guidelines 2015 asthamaJegon Varakala
 
ASTHMA GINA CLASSIFICATION
ASTHMA GINA CLASSIFICATIONASTHMA GINA CLASSIFICATION
ASTHMA GINA CLASSIFICATIONDJ CrissCross
 
Asthma complications in children pediatrics 4.pptx
Asthma complications in children pediatrics 4.pptxAsthma complications in children pediatrics 4.pptx
Asthma complications in children pediatrics 4.pptxArun170190
 
Asthma medical, nursing managements
Asthma medical, nursing managementsAsthma medical, nursing managements
Asthma medical, nursing managementsReynel Dan
 
Management of Chronic Asthma2-1.ppt
Management of Chronic Asthma2-1.pptManagement of Chronic Asthma2-1.ppt
Management of Chronic Asthma2-1.pptKemi Adaramola
 
Theophyllin in Asthma Patient
Theophyllin in Asthma PatientTheophyllin in Asthma Patient
Theophyllin in Asthma PatientRodolfo Rafael
 
Asthma lecture 100829
Asthma lecture 100829Asthma lecture 100829
Asthma lecture 100829Neil Kao
 
Albuterol sulfate
Albuterol sulfateAlbuterol sulfate
Albuterol sulfatewild727
 
Asthma Guide for Management
Asthma Guide for ManagementAsthma Guide for Management
Asthma Guide for Managementmeducationdotnet
 
Bronchial asthma madi sasi 2019
Bronchial  asthma madi sasi  2019Bronchial  asthma madi sasi  2019
Bronchial asthma madi sasi 2019cardilogy
 

Similar to Self Management of Asthma (20)

gina guidelines 2015 asthama
gina guidelines 2015 asthamagina guidelines 2015 asthama
gina guidelines 2015 asthama
 
ASTHMA GINA CLASSIFICATION
ASTHMA GINA CLASSIFICATIONASTHMA GINA CLASSIFICATION
ASTHMA GINA CLASSIFICATION
 
Asthma
Asthma Asthma
Asthma
 
Asthma complications in children pediatrics 4.pptx
Asthma complications in children pediatrics 4.pptxAsthma complications in children pediatrics 4.pptx
Asthma complications in children pediatrics 4.pptx
 
Asthma Project
Asthma ProjectAsthma Project
Asthma Project
 
Asthma medical, nursing managements
Asthma medical, nursing managementsAsthma medical, nursing managements
Asthma medical, nursing managements
 
Management of Chronic Asthma2-1.ppt
Management of Chronic Asthma2-1.pptManagement of Chronic Asthma2-1.ppt
Management of Chronic Asthma2-1.ppt
 
Theophyllin in Asthma Patient
Theophyllin in Asthma PatientTheophyllin in Asthma Patient
Theophyllin in Asthma Patient
 
Asthma lecture 100829
Asthma lecture 100829Asthma lecture 100829
Asthma lecture 100829
 
Bronchial asthma
Bronchial asthmaBronchial asthma
Bronchial asthma
 
Albuterol sulfate
Albuterol sulfateAlbuterol sulfate
Albuterol sulfate
 
Asthma Guide for Management
Asthma Guide for ManagementAsthma Guide for Management
Asthma Guide for Management
 
Asthma
Asthma  Asthma
Asthma
 
Asthma
AsthmaAsthma
Asthma
 
Ptt 2
Ptt 2Ptt 2
Ptt 2
 
Asthma
AsthmaAsthma
Asthma
 
Bronchial asthma madi sasi 2019
Bronchial  asthma madi sasi  2019Bronchial  asthma madi sasi  2019
Bronchial asthma madi sasi 2019
 
Acute asthma what is new?
Acute asthma  what is new?Acute asthma  what is new?
Acute asthma what is new?
 
asthma word.pdf
asthma word.pdfasthma word.pdf
asthma word.pdf
 
Asthma
AsthmaAsthma
Asthma
 

More from Khairul Jessy

More from Khairul Jessy (8)

Sarcoidosis
SarcoidosisSarcoidosis
Sarcoidosis
 
Approach to a patient with Haemoptysis
Approach to a patient with HaemoptysisApproach to a patient with Haemoptysis
Approach to a patient with Haemoptysis
 
Lung abscess
Lung abscessLung abscess
Lung abscess
 
Pneumonia
PneumoniaPneumonia
Pneumonia
 
Immunotherapy in asthma
Immunotherapy in asthmaImmunotherapy in asthma
Immunotherapy in asthma
 
Tuberculosis and pregnancy
Tuberculosis and pregnancyTuberculosis and pregnancy
Tuberculosis and pregnancy
 
Management of asthma
Management of asthmaManagement of asthma
Management of asthma
 
Smart therapy
Smart therapySmart therapy
Smart therapy
 

Recently uploaded

call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️9953056974 Low Rate Call Girls In Saket, Delhi NCR
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptxVS Mahajan Coaching Centre
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
Pharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfPharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfMahmoud M. Sallam
 
Blooming Together_ Growing a Community Garden Worksheet.docx
Blooming Together_ Growing a Community Garden Worksheet.docxBlooming Together_ Growing a Community Garden Worksheet.docx
Blooming Together_ Growing a Community Garden Worksheet.docxUnboundStockton
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxOH TEIK BIN
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformChameera Dedduwage
 
internship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developerinternship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developerunnathinaik
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxNirmalaLoungPoorunde1
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Celine George
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsanshu789521
 
Final demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxFinal demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxAvyJaneVismanos
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
 
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting DataJhengPantaleon
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Celine George
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxGaneshChakor2
 
How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17Celine George
 

Recently uploaded (20)

call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
Pharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfPharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdf
 
Blooming Together_ Growing a Community Garden Worksheet.docx
Blooming Together_ Growing a Community Garden Worksheet.docxBlooming Together_ Growing a Community Garden Worksheet.docx
Blooming Together_ Growing a Community Garden Worksheet.docx
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptx
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy Reform
 
internship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developerinternship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developer
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptx
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha elections
 
Final demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxFinal demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptx
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
 
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptx
 
How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17
 
9953330565 Low Rate Call Girls In Rohini Delhi NCR
9953330565 Low Rate Call Girls In Rohini  Delhi NCR9953330565 Low Rate Call Girls In Rohini  Delhi NCR
9953330565 Low Rate Call Girls In Rohini Delhi NCR
 

Self Management of Asthma

  • 1. Dr. Md. Khairul Hassan Jessy Associate Professor Respiratory Medicine NIDCH,Mohakhali,Dhaka Self Management of Asthma
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9. Introduction To define the self management plan To highlight the importance To discuss the detailed procedure Conclusion
  • 10. In the last few years there have been remarkable progress and outstanding improvement in the management of Asthma
  • 11. But sadly, many patients of developing countries are getting unplanned & unscientific management
  • 12. With education, caution & medication most cases of asthma can be effectively managed
  • 13. History  Asthma was first recognized in ancient Egypt & treatment was inhalation of frankincense Source : Wikipedia
  • 14.
  • 15. History…..  It was first recognized as a specific respiratory problem & named by Hippocrates
  • 17. History…  The most recent advancement is Combination of ICS & LABA with Adjustable Maintenance Dose (AMD) or Single Maintenance And Reliever Therapy (SMART)
  • 18.
  • 19. Asthma is a chronic inflammatory disease affecting the airways with typical symptoms of cough, wheezing, breathlessness & chest tightness
  • 20. Unified definition  Asthma is a chronic inflammatory disorder  causing hyper-responsiveness of the airways to certain stimuli  resulting in recurrent variable airflow limitation  at least partially reversible with treatment or spontaneously  manifested as shortness of breath, wheeze, cough and chest tightness
  • 21. It is not a curable disease But to a large extent It is controllable like Diabetes & Hypertension
  • 22. It is not a curable disease But to a large extent It is controllable like Diabetes & Hypertension
  • 23. Use of anti- inflammatory preventive drugs for 2-5 years may lead to Complete Remission in 60 – 80 % of Childhood asthma 20 – 30 % of Adult asthma
  • 24. But many serious episodes can be avoided by proper education and care at home
  • 26.
  • 27. Pharmacological management of Asthma… The mainstay of asthma therapy is the use of inhaled drugs the advantages of this method are that drugs are delivered direct to the airways and avoid passage to the liver
  • 28. Pharmacological management of Asthma… thus lower doses are necessary and systemic unwanted effect are minimized The drugs used in asthma should be given in a stepwise fashion according to the severity and frequency of the attacks
  • 29. Medicines of Asthma: Medicine used to treat asthma are basically three types A) Relievers B) Preventers C) Protectors
  • 30. A) Relievers These medicines relax smooth muscles that have tightened around the airways. They relieve asthma symptoms.
  • 31. A) Relievers (Bronchodilators)… 1. Short acting β2- agonists (SABA) Salbutamol Terbutaline 2. Short acting Xanthenes' derivatives Theophylline Aminophylline 3. Anticholinergics Ipratropium bromide Oxitropium bromide Tiotropium
  • 32. B) Protectors These medicines are long acting bronchodilator medicines  which prevent the recurrence of attacks particularly nocturnal symptoms.
  • 33. B) Protectors (Symptom controllers) 1) Long acting β2 agonist (LABA) Salmeterol Formoterol 2) Long acting Xanthene derivatives Theophylline Aminophylline 3) Sustained released Salbutamol
  • 34. C) Preventers medicines reduce or reverse the swelling in the airways These medicines also prevent the initiation of inflammation after exposure to trigger factors Thereby they prevent asthma episodes
  • 35. C) Preventers (Anti-inflammatory medicines) I)Corticosteroids •Inhaled •Oral II) Cromones •Nedocromil sodium •Sodium Cromoglycate III) Xanthene derivatives •Aminophylline and •Theophylline IV) Antileukotrienes •CysLT-1 receptor inhibitor: •Montelukast and •Zafirlukast •Enzyme inhibitor: Zileuton
  • 36. Newer and Disease modifying Drugs Newer Drugs Omalizumab (Xoliar) Magnesium Sulfate Frusemide Ciclesonide
  • 37. Newer and Disease modifying Drugs… Disease modifying agents Methotraxte, Cyclosporin-A & Gold-salts
  • 38. OMALIZUMAB (XOLIAR) Considerations for IgE blocker Therapy Monoclonal anti-IgE ab preparation Inhibit binding of IgE to mast cell – does not provoke mast cell degranulation
  • 39. OMALIZUMAB (XOLIAR) Considerations for IgE blocker Therapy…  Patient at least 12 years of age  Evidence of reversible disease (such as 12% or greater improvement in FEV1 with at least a 200- ml increase  or 20% or greater improvement in PEF)  IgE level ≥ 30 IU/ml
  • 40. OMALIZUMAB (XOLIAR) Considerations for IgE blocker Therapy…  Systemic corticosteroids or high-dose inhaled corticosteroids required to maintain adequate control  As directly observable therapy in patients who are not adherent to prescribed therapy
  • 41. OMALIZUMAB (XOLIAR) Considerations for IgE blocker Therapy…
  • 42.
  • 43. An overview of asthma triggers
  • 44.
  • 45.
  • 46.
  • 47.
  • 48.
  • 49.
  • 50. Asthma Triggers…  A trigger is anything that irritates the airways and causes the symptoms of asthma  Normal healthy person is not bothered by those triggers
  • 51. Asthma Triggers… Everyone's asthma is different and you may have several triggers An important aspect of controlling your asthma is avoiding your triggers It may be impossible to avoid all of your triggers
  • 52. Asthma Triggers…  but once you've identified them  there are things you can do to help you to reduce unnecessary symptoms and better control of your asthma
  • 53. Unhealthy indoor environment for asthma patient
  • 54. Asthma Triggers… Why To identify asthma triggers? To prevent some asthma attacks To reduce the frequency and severity of some attacks
  • 55. The patient is trying to control his asthma without removing trigger factor
  • 56. Asthma Triggers… Detection of trigger by monitoring the lung function
  • 57.
  • 58. To control asthma, PEP (Positive Expiratory Pressure) is so important that if they are educated properly, then- 73% of hospital admission from acute attack of asthma can be reduced and 80% of death from asthma can be prevented
  • 59.
  • 60. Effortless easy breathing - is our goal 24 hours a day 30 days a month 12 months a year -with an intention for full remission
  • 61.
  • 62. Non- Pharmacological - Education - Caution Pharmacological - Medications used in management
  • 63. We should educate our people in their own language Based on - our scientific knowledge - less scientific terminology - less comprehensive patho-physiology
  • 65. Patients? Physicians? Healthcare system? Asthma control Who is responsible for asthma control? Researchers?
  • 66. 41.1 14.5 35.4 Asia PacificEuropeUSA % of patients 100 0 80 60 20 40 Rabe et al. Eur Respir J 2000; www.asthmainamerica.com; Lai et al. J Allergy Clin Immunol 2003 Patients with persistent asthma receiving controller therapy
  • 67.
  • 68. Asthma control in practice was poor Doctors didn't follow  guidelines,  underestimate severity and  may confuse severity with control
  • 69. Patients underestimate the severity of their own disease Guidelines were complex and can be difficult to follow Only 5% of patients achieved GINA-defined control
  • 70. Control of asthma means, patient- is almost asymtomatic can perform normal daily activities requires reliever bronchodilator(sulbutamol inhalation)<1 time a day
  • 71. is free of nocturnal symptoms; if occurs , less than two times per month has PEFR reading >80% of personal best result has <10% diurnal variability in Peak Flow Chart, if available
  • 72.  has no history of emergency visit to doctors or hospitals  has no or minimal side effects of medication
  • 73. If we educate our patient properly Then patient will cautiously avoid allergens to control bronchial asthma They will use their medications with an intension to get remission
  • 74. Includes – Home Management - of stable asthma Emergency Management -Loss of control of asthma -Difficult to treat asthma
  • 75. Asthma is a chronic disease and it should be managed at home, except severe acute asthma  If home management plan is applied intelligently and skillfully most asthmatics can lead a symptom-free near-normal life  They may avoid hospitalization thereby decreasing the financial expenditure significantly
  • 76. There are two types of plans  without self-management plan  with guided self-management plan
  • 77.  The patient is educated  Appropriate precautionary measures are advised  “Step care management’’ is employed
  • 78.  The prescription is quite inflexible whatever be the condition  patient will not increase the drugs except β 2 agonist ( salbutamol ) inhaler  Salbutamol inhaler may be taken as per need upto 4-6 times / day
  • 79.
  • 80.
  • 81. Development of a guide on the basis of best Peak Flow is known as guided self management plan. Patient will measure his lung function with the help of a peak flow meter and on the basis of best peak flow results, patients will modify their treatment.
  • 83.  lead a symptom free near normal life  avoid many serious episodes of acute asthma &  Chances of mortality and morbidity is reduced considerably
  • 84.  Time consuming  More laborious  Needs patient compliance
  • 85. Flow meters are devices to measure the strength of airways (force of inspiration and expiration)
  • 86. Types of flow meters are  Peak expiratory flow meter ( peak flow meter)  Incentive Spirometer  Peak inspiratory flow meter ( PIF )
  • 87.  The measurement of peak expiratory flow was pioneered by Martin Wright  who produced the first meter to measure lung function
  • 88.  The original design of instrument was introduced in the late 1950s  and the subsequent development of a more portable, lower cost version is the "Mini- Wright" peak flow meter
  • 89.
  • 90. Who Should Use a Peak Flow Meter? People with moderate-to-severe asthma should have a peak flow meter at home. Even Peak flow meters are very helpful if a child have moderate to severe asthma and require daily asthma medications. Most children ages 6 and up may be able to use a peak flow meter.
  • 91. PEF(Peak expiratory flow): It is the highest flow one can achieve during forceful expiration
  • 92. The peak flow meter measures how fast air comes out of the lungs when a person exhale forcefully after inhaling fully
  • 93. Inexpensive, portable & handy device. Only measures the amount of airflow out of the large airways of the lungs. Small airways (which also occur with asthma) will not be detected by a peak flow meter. Depends on a patient's sex, age and height.
  • 94.
  • 95.  Move the marker to the bottom of the numbered scale.  Stand up if you're able.  Take a deep breath, filling your lungs completely.  Place your lips tightly around the mouthpiece.
  • 96.  Blow as hard and as fast as you can with a single breath.  Note the final position of the marker. This is your peak flow rate.  Follow the steps above then blow into the peak flow meter two more times.  Best of 3 blows is recorded.
  • 97.
  • 98.
  • 99. To recognize early changes that may be signs of worsening asthma and thus preventing asthma attack. During an asthma attack, the muscles in the airways tighten and cause the airways to narrow. The peak flow meter alerts you to the tightening of the airways often hours or even days before the development of asthma symptoms.
  • 100. By following the steps in asthma action plan, patient may be able to stop the narrowing of the airways quickly and avoid a severe asthma emergency
  • 101. Mainly Used to find out  early asthma attack (long before the onset of symptoms) &  by doubling the medicine a serious episode can be avoided  Used as a short term monitoring tool at Doctor’s chamber & emergency room during exacerbations
  • 102. Long term monitoring of asthma at patient’s home by maintaining peak flow chart essential for constructing self management plan
  • 103. Can also be used to see whether the management plan is working or not  to decide when to add or stop medicine  to decide when the patient seeks emergency care  to identify triggers
  • 104. By using own PEF with his/her asthma action plan, he/she will know when to take his/her rescue asthma inhaler or other asthma medicine.
  • 105. Diurnal variability = (highest PEF – lowest PEF)X100 highest PEF
  • 106. How to take care of Peak Flow Meter? Most peak flow meters require weekly cleaning with warm water and a mild detergent.
  • 107. PEF varies throughout the day. In a person who does not have asthma, it may vary between 10% and 15%.  In a person who has poorly controlled asthma, it may vary more than 20%.
  • 110.
  • 111. The highest peak flow measurement of a patient achieved over a two week period when patient’s asthma is totally/ well controlled “Self management plan” needs to be constructed depending on his own personal best peak flow value A person's personal best is his or her highest peak flow.
  • 112. Determine by taking readings over 2 weeks when the asthma is under control. Should be recorded at least twice daily. Best is usually reached in the evening. Never measured during an asthma attack.
  • 113. Patient will- Record his personal best peak flow result in the prescribed peak flow diary or chart 3 zones will be demarcated in the diary Take peak flow reading every morning on waking up and night at bedtime Peak flow readings should be taken at the same time each day They will also write down if they were exposed to any trigger factor’s initiating an attack.
  • 114. Patient will-  Peak expiratory flow is lowest in the early morning and highest in the afternoon.  If patient wants to take the test only one time during the day, they should take it first in the morning, before using a bronchodilator medicine.  note how many times they took extra reliever asthma medicine to stop their symptoms every day
  • 115. ( 3 basic steps )( 3 basic steps ) Step 1Step 1 Patient will measure the lung function with peak flow meter & maintain a peak flow chart
  • 116. ( 3 basic steps ) Step 2 With this chart - patient’s personal best peak flow result is determined On that basis readings are recorded in a chart with 3 color zones : Green,Yellow, Red
  • 118. ( 3 basic steps ) Step 3 Physician will develop one prescription for each zone Patient is educated to modify drugs up to a certain limit
  • 119. Peak Flow Zone System
  • 120. 3 traffic light colors are used to measure the control of asthma Green Yellow Red
  • 121.
  • 122. Green zone indicates well controlled asthma
  • 123. Green zone ( safety zone ) peak flow 100 - 80 % of personal best no/minimal symptoms maintenance therapy continues inhaled β 2 agonists may be used in some specific situations ( before exercise / mild symptoms)
  • 124. Yellow zone ( zone of alert ) - PEF is < 80 –> 60 % of personal best o Asthma symptoms – cough ( nocturnal ) breathlessness wheezing may be present
  • 125. Yellow zone ( zone of alert )… suggestive of –  Acute exacerbation or gradual deterioration of severity of asthma  Consultation with physician is needed .  Patient will double his preventer drug and take one or two oral protector drugs.
  • 126.  Red zone ( zone of emergency ) This signals a medical alert o PEF is < 60 % of personal best o Asthma symptoms are present at rest and interferes activity o β 2 agonist should be taken immediately o patient will start rescue oral steroid & o should contact the physician ( may need hospitalization )
  • 127. Red Zone means Along with prescription of yellow Zone  patient will start rescue oral steroid and  should contact a physician immediately
  • 128. Scenario 1: Mr. X , 45 years - known case of bronchial Asthma & Allergic Rhinitis  Personal best peak flow result =500L/min  Present PEFR = 420 l/min Questions: 1.PEF Zone? 2.What treatment to be given?
  • 129. Ans. 1. Green Zone 2.Rx Inhaler Fluticasone/Salmaterol (125/25) 2 puffs 12 hourly (contd) (gargle after use) Inhaler Salbutamol 2 puffs SOS Tab. Montelukast 10 mg 0+0+1(contd) Tab. Fexofenadine 120/Rupatidine 10 0+0+1 SOS Fluticasone nasal spray 2 puffs once daily in the morning (sos)
  • 130. Scenario 2: Mr. X , 45 years - known case of bronchial Asthma & Allergic Rhinitis Personal best peak flow result=500L/min Present PEFR = 350 l/min Questions: 1.PEF Zone? 2.What treatment to be given?
  • 131. Ans. 1.Yellow Zone 2.Rx: Inhaler Fluticasone/Salmaterol(250/25) 2 puffs 12 hourly (contd)(gargle after use) Inhaler Salbutamol 2 puffs sos Tab. Montelukast 10 mg 0+0+1(contd) Tab. Fexofenadine 120/Rupatidine 10 0+0+1 sos Theophylline S.R.(200 mg) 0+0+1 (contd) Fluticasone nasal spray 2 puffs once daily in the morning (contd)
  • 132. Scenario 3: Mr. X , 45 years - known case of bronchial Asthma & Allergic Rhinitis  Personal best peak flow result = 500 L/min  Present PEFR = 150 l/min Questions: 1.PEF Zone? 2.What treatment to be given?
  • 133. Ans. 1.Red Zone 2.Rx Tab. Prednisolone (20 mg) 2+0+0 (after meal) 7 days Tab. Esomoprazole (20 mg) 1+0+1 +treatment of yellow zone (to contact physician immediately)
  • 134. Asthma is not a curable disease But total/well control is possible in almost all cases by oproper Education otaking Caution ( regarding environmental control )& oNeed for Medication.
  • 135. Asthma is a chronic disease and it should be managed at home except severe acute asthma
  • 136.
  • 137.